MD

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 511.16 M502.36 M458.36 M468.84 M492.88 M493.77 M 1.91 B Gross profit 511.16 M502.36 M458.36 M468.84 M492.88 M493.77 M 1.91 B Operating expenses 477.33 M463.07 M426.26 M408.98 M424.82 M444.98 M 1.71 B Selling/general/admin expenses 58.12 M63.55 M58.6 M55.71 M60.79 M65.68 M 240.79 M Research & development —————— — Operating income -65.61 M39.29 M32.1 M59.87 M68.05 M48.79 M 208.81 M Non-Operating Income, Total 8.59 M5.96 M4.01 M4.9 M19.73 M-21.02 M 7.62 M Interest expense, net of interest capitalized 10.13 M9.71 M9.15 M9.13 M8.94 M8.74 M 35.97 M Non-Operating Income, excl. Interest Expenses -1.53 M-3.75 M-5.14 M-4.23 M10.79 M-29.76 M -28.35 M Unusual income/expense —————— — Pretax income 25.23 M-99.45 M28.09 M54.97 M87.78 M45.59 M 216.43 M Equity in earnings 445 K917 K406 K505 K1.88 M843 K 3.63 M Taxes -13.37 M2.85 M7.35 M15.71 M16.07 M11.91 M 51.04 M Non-controlling/minority interest —0———— — After tax other income/expense 328 K966 K758 K743 K1.89 M1.18 M 4.56 M Net income before discontinued operations 19.44 M-77.43 M20.74 M39.26 M71.71 M33.68 M 165.39 M Discontinued operations —0———— — Net income 19.44 M-77.43 M20.74 M39.26 M71.71 M33.68 M 165.39 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 19.44 M-77.43 M20.74 M39.26 M71.71 M33.68 M 165.39 M Basic earnings per share (Basic EPS) 0.230.370.250.460.850.41 1.97 Diluted earnings per share (Diluted EPS) 0.230.370.240.460.840.4 1.94 Average basic shares outstanding 83.89 M83.33 M84.44 M84.8 M84.61 M84.08 M 337.92 M Diluted shares outstanding 84.52 M83.33 M85.43 M85.53 M85.61 M85.27 M 341.84 M EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 6.25 M6.87 M5.33 M5.31 M5.55 M5.63 M 21.83 M